Table 4. Work productivity outcomes in uncontrolled asthma and severe asthma.
| WPAI:GH questionnaire | Patients grouped by ACQ score | Patients grouped by GINA step 4/5 or not | |||||
|---|---|---|---|---|---|---|---|
| Controlled asthma | Uncontrolled asthma | P value | Non-severe asthma | Severe asthma | P value | ||
| Participants currently workingc | 70/139 (50.4%) | 30/62 (48.4%) | 0.796 | 80/164 (48.8%) | 20/40 (50.0%) | 0.890 | |
| Any productivity lossc | 23/46 (50.0%) | 18/21 (85.7%) | 0.007 | 30/50 (60.0%) | 11/17 (64.7%) | 0.731 | |
| Absenteeismc | 4/46 (8.7%) | 6/21 (28.6%) | 0.060 | 7/50 (14.0%) | 3/17 (17.7%) | 0.706 | |
| Presenteeismc | 29/61 (47.5%) | 23/27 (85.2%) | 0.001 | 41/68 (77.3%) | 11/20 (55.0%) | 0.672 | |
| % absenteeismb | 0 (0, 0) | 0 (0, 33.33) | 0.019 | 0 (0, 0) | 0 (0,0) | 0.780 | |
| % presenteeismb | 0 (0, 20) | 30 (10, 50) | <0.0001 | 10 (0, 30) | 10 (0, 40) | 0.642 | |
| % work productivity loss | 2.54 (0, 20) | 50 (20, 64) | <0.0001 | 10 (0, 40) | 20 (0, 40) | 0.602 | |
| % activity impairmentb | 10 (0, 30) | 30 (20, 60) | <0.0001 | 20 (0, 50) | 10 (0, 30) | 0.237 | |
| Hours missed due to health problemsb; range | 0 (0, 0); 0–24 | 0 (0,8); 0–48 | 0.006 | 0 (0, 0); 0–48 | 0 (0, 0); 0–24 | 0.468 | |
WPAI, work productivity and activity impairment. Data given as bmedian (Q1, Q2), cNo. (%), Chi2 test or Fisher’s exact test. Italic face indicates significant.